Cancer Immunology – News and Features
News
Lumera Receives Order from BRI for a ProteomicProcessor Biosensor
Researcher team at Baylor Research Institute plans to use the ProteomicProcessor™ to measure serum protein levels.
News
FDA Grants Biovest International Fast Track Status for BiovaxID™
Biovest is now eligible to submit a biologics license application (BLA) on a rolling basis.
News
Soluble LAG-3 Protein is a Prognostic Factor in Breast Cancer
The results pave the way for the testing of a recombinant sLAG-3 protein as an adjuvant therapy for breast cancer in clinical trials.
News
Eden Biodesign and Onyvax Limited Announce Biomanufacturing Contract
Eden will supply cGMP clinical manufacturing services to Onyvax for its Cell Vaccine program in ovarian cancer.
News
Brain Cancer Patients Living Longer After Personalized Vaccine Therapy
Patients are surviving twice as long with DCVax®-Brain as with other therapeutics.
News
Searle Family to Fund Biomedical Research in Chicago
The consortium represents an avenue for collaborative interactions among researchers and institutional leaders from the three universities.
News
Caprion Announces Biomarker Discovery Collaboration with ICOS
The agreement in biomarker discovery will use Caprion's CellCarta® proteomics discovery platform.
News
Biologicals Manufacturing Conference
The 3rd Annual Biologicals Manufacturing conference draws on the experience of several biotechs from across Europe and will deliver case studies of their experiences in this field.
News
Cell Genesys San Diego Manufacturing Operation Acquired by Genzyme
Genzyme has acquired Cell Genesys' manufacturing operation to support the growth of Genzyme's gene therapy programs.
News
Trillium Acquires Arthron Ltd.
This acquisition executes TTI’s strategy of building a quality R&D portfolio of immunology-related assets.
Advertisement
